Abstract
Transurethral resection of bladder tumors (TURBT) represents the cornerstone in diagnosis and treatment of bladder cancer but recurrence is observed in up to 80% and over- or understaging with TURBT is common. A more recent development to overcome these limitations represents en-bloc resection of bladder tumors (ERBT) which offers several advantages over TURBT. In this report, we briefly review studies assessing outcomes of bladder cancer patients undergoing ERBT. Most randomized and non-randomized trial demonstrate improvement in clinical outcomes for ERBT over TURBT, however more pathological and translational studies are warranted.
Highlights
Bladder cancer has an estimated 429,793 new diagnoses leading to 165,084 deaths per year worldwide [1] but with a globally wide variation [2]
A recent consensus agreed that any method “removing the bladder tumor in one piece” can be described as en-bloc transurethral resection of bladder tumors (ERBT) [8]
We review studies assessing outcomes of patients with bladder cancer undergoing en-bloc resection of bladder tumors (ERBT)
Summary
Bladder cancer has an estimated 429,793 new diagnoses leading to 165,084 deaths per year worldwide [1] but with a globally wide variation [2]. Transurethral resection of bladder tumors (TURBT) represents the cornerstone in diagnosis and treatment of bladder cancer since the 1940s. To decrease the high recurrence rates, several new methodologies have been developed to allow en bloc removal of bladder cancers, for example in 1980 snare polypectomy a method which did not allow complete resection of the bladder base [6].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
